6,428 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Acquired by Stevens Capital Management LP

Stevens Capital Management LP bought a new position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,428 shares of the company’s stock, valued at approximately $249,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of BBWI. Fifth Third Wealth Advisors LLC grew its holdings in shares of Bath & Body Works by 4.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after purchasing an additional 324 shares during the last quarter. SRS Capital Advisors Inc. grew its stake in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares in the last quarter. TD Private Client Wealth LLC increased its position in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares during the period. UMB Bank n.a. raised its stake in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its holdings in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. set a $47.00 price objective on Bath & Body Works in a report on Thursday, February 27th. TD Cowen raised their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Raymond James reaffirmed an “outperform” rating and issued a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $42.00 to $48.00 in a report on Friday, January 10th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $45.06.

Read Our Latest Stock Report on Bath & Body Works

Bath & Body Works Trading Up 7.2 %

NYSE:BBWI opened at $32.47 on Tuesday. Bath & Body Works, Inc. has a twelve month low of $26.21 and a twelve month high of $52.99. The company has a market cap of $6.96 billion, a PE ratio of 7.92, a P/E/G ratio of 0.92 and a beta of 1.89. The company’s 50 day moving average is $35.62 and its two-hundred day moving average is $34.01.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s dividend payout ratio is presently 21.98%.

Bath & Body Works announced that its board has authorized a share buyback program on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.